Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis-Reference-Cited by-同舟云学术

Poly(I:C) Drives Type I IFN- and TGFβ-Mediated Inflammation and Dermal Fibrosis Simulating Altered Gene Expression in Systemic Sclerosis

Published:2010-11 Issue:11 Volume:130 Page:2583-2593
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Farina Giuseppina A.,York Michael R.,Di Marzio Michael,Collins Cindy A.,Meller Stephan,Homey Bernhard,Rifkin Ian R.,Marshak-Rothstein Ann,Radstake Timothy R.D.J.,Lafyatis Robert

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference49 articles.

1. Pathogen recognition and innate immunity;Akira;Cell,2006

2. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13;Aliprantis;Proc Natl Acad Sci USA,2007

3. Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis;Belperio;Am J Respir Cell Mol Biol,2002

4. Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial;Black;Arthritis Rheum,1999

5. Microarray analysis of interferon-regulated genes in SLE;Crow;Autoimmunity,2003

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Human Neonatal Skin Fibroblast, an Available Cell Source for Tissue Production and Transplantation, Exhibits Low Risk of Immunogenicity In Vitro;International Journal of Molecular Sciences;2024-06-26

2. Anti-Th/To Antibodies in Scleroderma: Good Prognosis or Serious Concern?;Journal of Clinical Medicine;2024-05-21

3. SLIRP promotes autoimmune diseases by amplifying antiviral signaling via positive feedback regulation;2024-04-02

4. Long non-coding RNA H19X as a regulator of mononuclear cell adhesion to the endothelium in systemic sclerosis;Rheumatology;2024-02-01

5. Genetic Factors;Scleroderma;2024